SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001437749-22-028113
Filing Date
2022-11-28
Accepted
2022-11-28 17:17:57
Documents
6

Document Format Files

Seq Description Document Type Size
1 dffn20221127_prer14a.htm PRER14A 543357
2 card01.jpg GRAPHIC 183622
3 dffn20221117_prec14aimg001.jpg GRAPHIC 7826
4 dffn20221117_prec14aimg002.jpg GRAPHIC 7339
5 dffn20221117_prec14aimg003.jpg GRAPHIC 7339
6 diff01.jpg GRAPHIC 383119
  Complete submission text file 0001437749-22-028113.txt   1356829
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37942 | Film No.: 221426868
SIC: 2834 Pharmaceutical Preparations